House Amendment A03371
H2162B2805A03371 LKK:EJH 06/01/26 #90 A03371AMENDMENTS TO HOUSE BILL NO. 2162Sponsor: REPRESENTATIVE BOROWSKIPrinter's No. 2805Amend Bill, page 1, lines 9 through 13, by striking out all of said lines and inserting Section 1. Section 3 of the act of December 14, 1992 (P.L.1116, No.145), known as the Wholesale Prescription Drug Distributors License Act, is amended by adding a definition to read:Amend Bill, page 1, line 19; page 2, lines 1 through 10; by striking out all of said lines on said pages and inserting "Conditional license." A temporary license issued by the department to a manufacturer or a virtual manufacturer for a drug or medical device that has not yet received final approval from the United States Food and Drug Administration.Amend Bill, page 2, lines 12 through 30; page 3, lines 1 through 10; by striking out all of said lines on said pages and inserting Section 2. Section 5 of the act is amended by adding a subsection to read:Section 5. License application.* * *(a.2) Conditional license.--(1) If the applicant is a manufacturer of a prescription drug or a virtual manufacturer of a drug or medical device that has not yet received approval from the United States Food and Drug Administration, the department may issue a conditional license if the applicant submits all of the following:(i) Documentation demonstrating that an application for approval has been submitted to the United States Food and Drug Administration, including, where applicable:(A) a new drug application number;(B) an abbreviated new drug application number;(C) a biologics license application number;(D) a unique device identification number; or2026/90LKK/HB2162A03371 - 1 -123456789101112131415161718192021222324252627282930313233
(E) other documentation acceptable to the department demonstrating active review by the United States Food and Drug Administration.(ii) Documentation identifying any contract manufacturing organization or licensed manufacturing facility involved in the manufacture, packaging, labeling or distribution of the drug or medical device.(iii) Documentation demonstrating compliance with applicable requirements of 21 U.S.C. Ch. 9 Subch. V Pt. H (relating to pharmaceutical distribution supply chain).(2) A conditional license issued under paragraph (1):(i) shall expire one year after issuance unless renewed by the department;(ii) shall automatically expire upon denial, withdrawal or refusal of the applicant's approval application by the United States Food and Drug Administration;(iii) may not authorize commercial distribution of a drug or device unless otherwise permitted under Federal law; and(iv) does not create a property interest in the conditional license and may be suspended or revoked by the department for failure to maintain compliance with this act or applicable Federal law.(3) An applicant issued a conditional license under paragraph (1) shall notify the department within five business days of:(i) approval, denial, withdrawal or refusal of an application by the United States Food and Drug Administration; or(ii) any material change to the applicant's manufacturing or distribution arrangements.(4) Issuance of a conditional license or a license under this subsection may not be construed as approval, endorsement or authorization of a drug or medical device by the Commonwealth.(5) The department may promulgate regulations and develop monitoring, reporting and enforcement procedures necessary to implement this subsection.(6) Upon satisfactory proof provided by the conditional licensee to the department that all conditions for licensure have been met, the department shall convert the conditional license into a license within 30 days.* * *2026/90LKK/HB2162A03371 - 2 -1234567891011121314151617181920212223242526272829303132333435363738394041424344
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.